SPARKS

• Research type

  Research Study

• Full title

  Simpler and Safer Deep Brain Stimulation for Parkinson’s

• IRAS ID

  166307

• Contact name

  Alan Whone

• Contact email

  alan.whone@btinternet.com

• Sponsor organisation

  North Bristol NHS Trust

• Duration of Study in the UK

  3 years, 0 months, 1 days

• Research summary

  High frequency Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) is an effective and established treatment for moderate to advanced Parkinson's disease (PD). Bioinduction Medical have developed a new DBS device, Picostim, for this application with improved technology, a skull mounted system, and reduced surgical risks and duration. This single-centre, prospective, open label, non-randomised pilot (Class III AIMD) study will evaluate Picostim in 25 PD patients at 12, 26 and 52 weeks post-implantation, with respect to motor and non-motor function, quality of life, mood, and cognition; ease of use and patient experience; and cost and resource use.

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  15/SW/0309

• Date of REC Opinion

  12 Nov 2015

• REC opinion

  Favourable Opinion